Jeffrey H. Burbank, Chief Executive Officer at NxStage Medical, Inc. (NXTM), sold 20,000 shares at $15.38 ($311K) on 2015-06-17, disclosed to the SEC on 2015-06-19.
Scheduled sale ($311k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.38 | 10,000 | $154K | 49.4% |
| 2 | $15.74 | 10,000 | $157K | 50.6% |
| Total | $15.56 avg | 20,000 | $311K | 100% |
| Filing → |
| NXTM | SELL | 2017-03-23 | $82K | — | Filing → |
| NXTM | SELL | 2017-03-22 | $83K | — | Filing → |
| NXTM | SELL | 2017-02-24 | $217K | — | Filing → |